Normalization of the H3K9me2/H3K14ac-FosB pathway in the nucleus accumbens underlying the reversal of morphine-induced behavioural and synaptic plasticity by Compound 511

Qisheng Wang,Fenfen Qin,Yuxuan Wang,Zijing Wang,Weixin Lin,Zhonghao Li,Qingyang Liu,Xinru Mu,Hui Wang,Shang Lu,Yongwei Jiang,Shengfeng Lu,Qian Wang,Zhigang Lu

DOI: https://doi.org/10.1016/j.phymed.2022.154467

IF: 6.656

2023-01-01

Phytomedicine

Abstract:Background: Although opioid agonist-based treatments are considered the first-line treatment for opioid use disorders, nonopioid alternatives are urgently needed to combat the inevitable high relapse rates. Compound 511 is a formula derived from ancient traditional Chinese medical literature on opiate rehabilitation. Previously, we observed that Compound 511 could effectively prevent the acquisition of conditioned place preference (CPP) during early morphine exposure. However, its effects on drug-induced reinstatement remain unclear. Purpose: This study aims to estimate the potential of Compound 511 for the therapeutic intervention of opioid relapse in rodent models and explore the potential mechanisms underlying the observed actions.Study design/Methods: The CPP and locomotor sensitization paradigm were established to evaluate the thera-peutic effect of Compound 511 treatment on morphine-induced neuroadaptations, followed by immunofluo-rescence and western blot (WB) analysis of the synaptic markers PSD-95 and Syn-1. Furthermore, several addiction-associated transcription factors and epigenetic marks were examined by qPCR and WB, respectively. Furthermore, the key active ingredients and targets of Compound 511 were further excavated by network pharmacology approach and experimental validation. Results: The results proved that Compound 511 treatment during abstinence blunted both the reinstatement of morphine-evoked CPP and locomotor sensitization, accompanied by the normalization of morphine-induced postsynaptic plasticity in the nucleus accumbens (NAc). Additionally, Compound 511 was shown to exert a selectively repressive influence on morphine-induced hyperacetylation at H3K14 and a reduction in H3K9 dimethylation as well as Delta FosB activation and accumulation in the NAc. Finally, two herbal ingredients of Compound 511 and six putative targets involved in the regulation of histone modification were identified. Conclusion: Our findings indicated that Compound 511 could block CPP reinstatement and locomotor sensiti-zation predominantly via the reversal of morphine-induced postsynaptic plasticity through epigenetic mecha-nisms. Additionally, 1-methoxy-2,3-methylenedioxyxanthone and 1,7-dimethoxyxanthone may serve as key ingredients of Compound 511 by targeting specific epigenetic enzymes. This study provided an efficient non-opioid treatment against opioid addiction.